Pyrazinamide (PZA) is a unique frontiline drug for shortening tuberculosis treatment, but its 24 mechanisms of action are elusive. We previously identified RpsA as a target of PZA and found 25 an alanine deletion at position 438 (Δ438A) in RpsA associated with PZA resistance, but its 26 role in PZA resistance is controversial. Here, we introduced RpsA mutation Δ438A or D123A 27 into M. tuberculosis chromosome and demonstrated that the introduced RspA mutations are 28 indeed responsible for PZA resistance.
In this study, to more convincingly address the role of the RpsA ∆438A mutation in PZA 58 resistance, we transferred this mutation into the genome of M. tuberculosis H37Rv by 59 homologous recombination. It is worth noting that the same strategy has been successfully used 60 to demonstrate inhA and certain embB point mutations being responsible for INH and 61 ethambutol resistance, respectively (10, 22). The RpsA ∆438A mutation was created by a two-62 step allelic exchange method as described (8). Briefly, a 3,440-bp fragment spanning the rpsA 63 ∆438A deletion mutation was amplified by PCR with DHM444 genomic DNA using primers 64 containing HindIII and PacI restriction sites (underlined) in the forward primer (FrpsA 5'-65 CGGAAGCTTCCACACCACGTTCAACCAGAC-3' and reverse primer RrpsA 5'-66 4 GCTTAATTAAGCACGCGCTTGTGCCACAGAG-3'), respectively. The PCR fragment was 67 then cloned into the p2NIL vector followed by insertion of a PacI cassette containing the sacB 68 and lacZ. The recombinant plasmid was transformed in M. tuberculosis H37Rv as described 69 (12). The desired sucrose-resistant but kanamycin-susceptible transformants were analyzed by 70 PCR and sequenced to confirm that the transformed M. tuberculosis has the correct RpsA 71 ∆438A mutation ( Fig. 1) . We determined the PZA MICs for the RpsA ∆438A mutant and the 72 parent strain M. tuberculosis H37Rv using the proportion method and found them to be 200 73 μg/ml and 100 μg/ml (pH5.8), respectively. In addition, we measured the PZA and POA MICs 74 for the RpsA ∆438A mutant in liquid 7H9 medium (pH5.8) using microdilution method. The
75
PZA MIC for the M. tuberculosis RpsA ∆438A mutant strain was 300 μg/ml while the parent 76 strain H37Rv was susceptible at this concentration ( Fig. 2A) . The POA MIC for the M. 77 tuberculosis RpsA ∆438A mutant strain was 50 μg/ml compared with 25 μg/ml for the parent 78 strain H37Rv (Fig. 2B ). On the other hand, both strains had the same MIC for the control drugs 79 isoniazid (INH) (0.03 μg/ml) and rifampin (RIF) (0.12 μg/ml) ( Fig. 2C, 2D provides clear evidence that its PZA resistance is most likely due to the RpsA ∆438A mutation 111 ( Fig. 2A, 2B ). 
